Table 1.

Patient characteristics.

Variables	Total (n = 48)
Age (yr)	53.1 ± 10.6
Gender (male)	23 (47.9%)
BMI (kg m−2)	24.2 ± 3.1
ASA class (I/II)	25 (52.1%)/23 (47.9%)
Anesthesia duration (min)	63.8 ± 12.3
Time to TOFR 90 (min)	1.7 ± 0.6
Effect site concentration of propofol at baseline* (μg ml−1)	3.0 ± 0.6
Effect site concentration of remifentanil at baseline* (ng ml−1)	2.0 ± 0.8
Total propofol consumption (mg)	532.1 ± 159.0
Total remifentanil consumption (mg)	0.4 ± 0.1
Total rocuronium consumption (mg)	48.1 ± 9.8

Data expressed as mean ± SD or n (%).

BMI body mass index, ASA American society of anesthesiologists, TOFR train of four ratio.

*Baseline was defined as the time point at which sugammadex was administered.